Abbott Laboratories is a medical device and healthcare company with a market capitalization of approximately 187 bln USD. This number was calculated based on data from the NYSE and the most recent market cap estimate of 185.9 bln USD as of February 3rd 2023. The stock price has seen an increase of 0.0186% in the last 24 hours, with a low of 106.28 and a high of 107.31, while the average 50-day price is 109.90 and the average 200-day price is 107.25.
The company’s earnings per share (EPS) is currently at 3.91, with a P/E ratio of 27.44 times its current share price, indicating it is trading above its intrinsic value. Furthermore, Abbott Laboratories announced their earnings for quarter ending April 18th 2023 on February 3rd 2023 with an outstanding 174 357 0048 shares issued and outstanding at that time.
Overall, Abbott Laboratories’ financial health appears to be strong based on their market capitalization and current stock performance metrics. Moreover, they have consistently reported positive EPS growth over the past few years, suggesting that they are well positioned to continue growing in 2021 given their strong fundamentals and sustained product demand in their target markets.
